ArticleTranslational cancer research2026

Durable benefits, but no improvements in overall survival: what can we learn from CheckMate 238 after 9 years of follow-up?

Carlos Diego Holanda Lopes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.